A STUDY OF THE PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVENOUSLY ADMINISTERED PEGASYS (PEGINTERFERON ALFA-2A) IN PATIENTS WITH CHRONIC HEPATITIS C AND PREVIOUS NON-RESPONSE TO PEGYLATED INTERFERON AND RIBAVIRIN COMBINATION THERAPY: